Quantum Genomics SA (ALQGC) — Cash Flow-to-Debt Ratio
Quantum Genomics SA (ALQGC) has a Cash Flow-to-Debt Ratio of -1.85x as of June 2023, meaning its operating cash flow of €-7.64 Million could theoretically repay -2% of its total liabilities (€4.13 Million) in one year. See how liquid is Quantum Genomics SA's working capital to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Quantum Genomics SA Cash Flow-to-Debt Ratio (2012–2022)
Historical debt coverage capacity for Quantum Genomics SA across 11 annual periods. Also explore ALQGC net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Quantum Genomics SA (2012–2022)
Year-by-year debt coverage analysis for Quantum Genomics SA. For market capitalisation and broader financial context, see market value of Quantum Genomics SA.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.01x | €-20.21 Million | €20.05 Million | ▲ +31.4% |
| 2021 | -1.47x | €-17.02 Million | €11.57 Million | ▲ +0.1% |
| 2020 | -1.47x | €-11.99 Million | €8.15 Million | ▲ +24.2% |
| 2019 | -1.94x | €-10.43 Million | €5.37 Million | ▼ -17.7% |
| 2018 | -1.65x | €-10.90 Million | €6.61 Million | ▼ -4.3% |
| 2017 | -1.58x | €-7.98 Million | €5.05 Million | ▲ +22.3% |
| 2016 | -2.04x | €-5.53 Million | €2.72 Million | ▼ -63.2% |
| 2015 | -1.25x | €-3.14 Million | €2.52 Million | ▼ -118.3% |
| 2014 | -0.57x | €-2.79 Million | €4.88 Million | ▼ -92.4% |
| 2013 | -0.30x | €-987.00K | €3.32 Million | ▲ +4.4% |
| 2012 | -0.31x | €-614.00K | €1.97 Million | — |